.

ISSN 2063-5346
For urgent queries please contact : +918130348310

PULMONARY PERFORMANCE IN PATIENTS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION

Main Article Content

Mohammed Yunis1 , Engy Osman2 , Ahmad Darwish1 , Khaled Fathy3 , Mona Mohammed Hafez4
» doi: 10.48047/ecb/2023.12.9.222

Abstract

Background: In adolescents and young adults who have refractory cancers, bone marrow failure syndromes, or primary immunological deficiencies, hematopoietic stem cell transplantation (HSCT) is a potentially curative therapy option. (Rotz et al., 2017). It has been observed that during the first year following hematopoietic stem cell transplantation (HSCT), up to 85 percent of pediatric patients experience a decline in their pulmonary function (PF).

Article Details